Literature DB >> 32234856

Suspected adverse reaction to compounded preparations prescribed for weight loss: two cases of cerebral venous thrombosis.

Beatrice Mainoli1,2, Mariana Carvalho Dias3, Patricia Canhão4,5, Mário Miguel Rosa1,2,5,6.   

Abstract

We report two cases of cerebral venous thrombosis associated with the use of compounded preparations containing several active substances prescribed for weight loss. In both cases there is suspicion of additive/synergic interaction with oral contraceptives. The adverse drug reactions were considered serious, being life-threatening and causing hospitalisation for days. © BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  drug misuse (including addiction); neurology (drugs and medicines); safety; stroke; unwanted effects / adverse reactions

Mesh：

Substances：

Year:  2020        PMID： 32234856      PMCID： PMC7167426          DOI： 10.1136/bcr-2019-233746

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


  27 in total

1.  Cerebral Venous Sinus Thrombosis Incidence Is Higher Than Previously Thought: A Retrospective Population-Based Study.

Authors:  Sharon Devasagayam; Ben Wyatt; James Leyden; Timothy Kleinig
Journal:  Stroke       Date:  2016-07-19       Impact factor: 7.914

Review 2.  Thrombosis of the cerebral veins and sinuses.

Authors:  Jan Stam
Journal:  N Engl J Med       Date:  2005-04-28       Impact factor: 91.245

Review 3.  Diagnosis and management of cerebral venous thrombosis: a statement for healthcare professionals from the American Heart Association/American Stroke Association.

Authors:  Gustavo Saposnik; Fernando Barinagarrementeria; Robert D Brown; Cheryl D Bushnell; Brett Cucchiara; Mary Cushman; Gabrielle deVeber; Jose M Ferro; Fong Y Tsai
Journal:  Stroke       Date:  2011-02-03       Impact factor: 7.914

4.  The return of rainbow diet pills.

Authors:  Pieter A Cohen; Alberto Goday; John P Swann
Journal:  Am J Public Health       Date:  2012-07-19       Impact factor: 9.308

5.  Cerebral sinus venous thrombosis during childhood acute lymphoblastic leukemia therapy: Risk factors and management.

Authors:  Khaled M Ghanem; Raghida M Dhayni; Carol Al-Aridi; Nidale Tarek; Hani Tamim; Anthony K C Chan; Raya Saab; Miguel R Abboud; Hassan El-Solh; Samar A Muwakkit
Journal:  Pediatr Blood Cancer       Date:  2017-06-29       Impact factor: 3.167

6.  Causes and predictors of death in cerebral venous thrombosis.

Authors:  Patrícia Canhão; José M Ferro; Arne G Lindgren; Marie-Germaine Bousser; Jan Stam; Fernando Barinagarrementeria
Journal:  Stroke       Date:  2005-07-07       Impact factor: 7.914

7.  Prevalence of weight-loss strategies and use of substances for weight-loss among adults: a population study.

Authors:  Eduardo Coelho Machado; Mariângela Freitas da Silveira; Vera Maria Freitas da Silveira
Journal:  Cad Saude Publica       Date:  2012-08       Impact factor: 1.632

8.  Cortical venous thrombosis following exogenous androgen use for bodybuilding.

Authors:  Olafur Sveinsson; Lars Herrman
Journal:  BMJ Case Rep       Date:  2013-02-05

9.  Recurrent venous thrombosis including cerebral venous sinus thrombosis in a patient taking sildenafil for erectile dysfunction.

Authors:  A Rufa; A Cerase; L Monti; M T Dotti; A Giorgio; F Sicurelli; A Federico
Journal:  J Neurol Sci       Date:  2007-06-18       Impact factor: 3.181

Review 10.  Potential risks of pharmacy compounding.

Authors:  Jennifer Gudeman; Michael Jozwiakowski; John Chollet; Michael Randell
Journal:  Drugs R D       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.